Laura Moreno

Laura Moreno-Martinez is member of the LAGENBIO (TERAGEN Y REGENERAGEN) group at the University of Zaragoza. The focus of her current research is the identification of novel diagnostic and prognostic biomarkers for ALS disease. She is also involved in the assessment of innovative therapeutic molecules for ALS in preclinical trials. Contact information: lauramm@unizar.es